Search filters

List of works by Gary Remington

"Extended" antipsychotic dosing in the maintenance treatment of schizophrenia: a double-blind, placebo-controlled trial

scientific article published on 07 September 2010

'Atypical' antipsychotics: where does ziprasidone fit?

scientific article published in January 2002

168. Neuroadaptations to Antipsychotic Drugs: Optimizing use of Current Medication Through a Deeper Understanding of Antipsychotic Drug Action in the Brain and Body.

scientific article published on 20 March 2017

67 Effects of Long-term Valbenazine on Psychiatric Status in Patients with Tardive Dyskinesia and a Primary Mood Disorder

A PET study evaluating dopamine D2 receptor occupancy for long-acting injectable risperidone

scientific article published in March 2006

A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone

scientific article published in May 2004

A comparison of cardio-metabolic risk between the deficit and non-deficit subtypes of schizophrenia

scientific article published on 19 January 2014

A cross-sectional study of plasma risperidone levels with risperidone long-acting injectable: implications for dopamine D2 receptor occupancy during maintenance treatment in schizophrenia

scientific article

A method to achieve extended cannabis abstinence in cannabis dependent patients with schizophrenia and non-psychiatric controls

scientific article published on 12 May 2017

A preliminary examination of the validity and reliability of a new brief rating scale for symptom domains of psychosis: Brief Evaluation of Psychosis Symptom Domains (BE-PSD).

scientific article published on 8 June 2016

A systematic review of reported cases involving psychotic symptoms worsened by aripiprazole in schizophrenia or schizoaffective disorder ⬇️

scientific article published on 05 June 2013

Abbreviated quality of life scales for schizophrenia: comparison and utility of two brief community functioning measures

scientific article published on 11 March 2014

Achievement motivation in early schizophrenia: Relationship with symptoms, cognition and functional outcome

scientific article published on 23 February 2017

Actigraphic measurement of the effects of single-dose haloperidol and olanzapine on spontaneous motor activity in normal subjects.

scientific article

Adherence to Clozapine vs. Other Antipsychotics in Schizophrenia

scientific article published on 06 July 2020

Adjunctive versus monotherapeutic treatment for schizophrenia: addressing antipsychotic side effects

scientific article published in March 2008

Alterations of dopamine and serotonin transmission in schizophrenia

scientific article published on January 2008

Amotivation and functional outcomes in early schizophrenia ⬇️

scientific article published on December 15, 2013

Amotivation is associated with smaller ventral striatum volumes in older patients with schizophrenia

scientific article published on 7 November 2017

An Examination of the Multi-Faceted Motivation System in Healthy Young Adults.

scientific article published on 11 May 2018

An algorithm-based approach to first-episode schizophrenia: response rates over 3 prospective antipsychotic trials with a retrospective data analysis

scientific article

Antipsychotic Dosing: Extended, and Transient

scientific article published on July 1, 2012

Antipsychotic Polypharmacy and Corrected QT Interval: A Systematic Review

scientific article

Antipsychotic dosing: how much but also how often?

scientific article

Antipsychotic dosing: still a work in progress

scientific article published in June 2010

Antipsychotic response in first-episode schizophrenia: efficacy of high doses and switching ⬇️

scientific article published on May 22, 2013

Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems

scientific article (publication date: 8 December 2010)

Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems

scientific article

Antipsychotics and amotivation

scientific article

Antipsychotics and schizophrenia: from efficacy and effectiveness to clinical decision-making

scientific article published on March 2010

Antipsychotics, dopamine D₂ receptor occupancy and clinical improvement in schizophrenia: a meta-analysis

scientific article published on 12 July 2012

Apathy in schizophrenia: clinical correlates and association with functional outcome

scientific article published in September 2003

Association Between Weight Gain and Remission Status at 3 Months in First-Episode Schizophrenia

scientific article published on 16 May 2016

Association of the orphan nuclear receptor NR4A1 with tardive dyskinesia

scientific article

Association study between a functional glutathione S-transferase (GSTP1) gene polymorphism (Ile105Val) and tardive dyskinesia

scientific article published in November 2005

Association study between the neurexin-1 gene and tardive dyskinesia

scientific article published in January 2017

Association study of Disrupted-In-Schizophrenia-1 gene variants and tardive dyskinesia

scientific article published on 15 August 2018

Association study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patients

scientific article published on 7 September 2006

Association study of the GSK-3B gene with tardive dyskinesia in European Caucasians

scientific article published on 3 June 2010

Association study of the vesicular monoamine transporter gene SLC18A2 with tardive dyskinesia

scientific article

Attribution style as a factor in psychosis and symptom resolution

scientific article published on 15 July 2008

Atypical antipsychotic-induced metabolic disturbances in the elderly

scientific article published on March 2014

Atypical antipsychotics and effects of adrenergic and serotonergic receptor binding on insulin secretion in-vivo: An animal model ⬇️

scientific article published on March 15, 2013

Augmentation strategies in clozapine-resistant schizophrenia

scientific article

Augmenting strategies in clozapine-resistant schizophrenia

scientific article published in January 2006

Baseline social amotivation predicts 1-year functioning in UHR subjects: A validation and prospective investigation

scientific article published on 30 October 2015

Behavioral effects of food-derived opioid-like peptides in rodents: Implications for schizophrenia?

scientific article published on 07 February 2015

Behavioural interventions for reducing weight gain in schizophrenia

scientific article

Beyond Pharmacotherapy: Understanding the Links between Obesity and Chronic Mental Illness ⬇️

scientific article published on January 1, 2012

Body composition, pre-diabetes and cardiovascular disease risk in early schizophrenia

scientific article published on 10 March 2015

Body mass index, waist circumference and quality of life in individuals with schizophrenia

scientific article published on 30 November 2006

Can Aripiprazole Worsen Psychosis in Schizophrenia? A Meta-Analysis of Double-Blind, Randomized, Controlled Trials

scientific article published on 6 March 2018

Canadian Treatment Guidelines for Individuals at Clinical High Risk of Psychosis

scientific article published in January 2017

Challenging the need for sustained blockade of dopamine D₂ receptor estimated from antipsychotic plasma levels in the maintenance treatment of schizophrenia: A single-blind, randomized, controlled study

scientific article published on 10 April 2015

Characterizing coronary heart disease risk in chronic schizophrenia: high prevalence of the metabolic syndrome

scientific article published in November 2004

Characterizing the affective responses to an acute bout of moderate-intensity exercise among outpatients with schizophrenia

scientific article

Chronic olanzapine administration in rats: Effect of route of administration on weight, food intake and body composition ⬇️

scientific article published on December 9, 2012

Clinical and functional outcomes in people with schizophrenia with a high sense of well-being

scientific article published in March 2015

Clinical determinants of life satisfaction in chronic schizophrenia: data from the CATIE study

scientific article

Clozapine and anemia: a 2-year follow-up study

scientific article published on December 2015

Clozapine and global cognition in schizophrenia

scientific article published on August 2010

Clozapine and therapeutic drug monitoring: is there sufficient evidence for an upper threshold?

scientific article

Clozapine exposure and the impact of smoking and gender: a population pharmacokinetic study

scientific article published on June 2009

Clozapine's role in the treatment of first-episode schizophrenia

scientific article published in February 2013

Clozapine-induced hypersalivation: a review of treatment strategies

scientific article published on June 2007

Comment: Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain

scientific article published on 29 June 2010

Comparative efficacy between clozapine and other atypical antipsychotics on depressive symptoms in patients with schizophrenia: analysis of the CATIE phase 2E data

scientific article

Comparing dopamine D(2) receptor occupancies for use in clinical practice: attractive proposition but fraught with pitfalls

scientific article published in August 2014

Consistency between clinician and patient ratings of clozapine-induced side effects

scientific article published on 15 April 2016

Continuous but not intermittent olanzapine infusion induces vacuous chewing movements in rats

scientific article published in February 2005

Daily activity patterns in remitted first-episode schizophrenia

scientific article

Defining treatment-resistant schizophrenia and response to antipsychotics: a review and recommendation

scientific article published on 18 March 2012

Determinants of patient-rated and clinician-rated illness severity in schizophrenia

scientific article published on July 2015

Determining rates of hepatitis C in a clozapine treated cohort

scientific article published on 6 July 2010

Differential effects of within-day continuous vs. transient dopamine D2 receptor occupancy in the development of vacuous chewing movements (VCMs) in rats

scientific article published on 2 July 2003

Direct activation of the ventral striatum in anticipation of aversive stimuli

scientific article

Dissecting negative symptoms in schizophrenia: opportunities for translation into new treatments

scientific article

Distress related to subclinical negative symptoms in a non-clinical sample: Role of dysfunctional attitudes

scientific article published on 5 September 2015

Dopamine D₂/₃ occupancy of ziprasidone across a day: a within-subject PET study

scientific article published on 17 February 2013

Dose reduction of risperidone and olanzapine and estimated dopamine D₂ receptor occupancy in stable patients with schizophrenia: findings from an open-label, randomized, controlled study

scientific article

Double-blind, placebo-controlled comparison of the efficacy of sertraline as treatment for a major depressive episode in patients with remitted schizophrenia

scientific article published on February 2002

Early prediction of clinical and functional outcome in schizophrenia

scientific article published on 7 November 2012

Early use of clozapine for poorly responding first-episode psychosis

scientific article published in August 2007

Effect of Antipsychotic Dosing Regimen on Neurocognition in Schizophrenia

scientific article published on 16 October 2015

Effect of acute antipsychotic administration on dopamine synthesis in rodents and human subjects using 6-[18F]-L-m-tyrosine.

scientific article published in May 2004

Effect of antipsychotic medication on overall life satisfaction among individuals with chronic schizophrenia: findings from the NIMH CATIE study

scientific article published on 15 March 2014

Effect of antipsychotic pharmacotherapy on clinical outcomes of intermittent theta-burst stimulation for refractory depression

scientific article

Effect of intrinsic motivation on cognitive performance in schizophrenia: a pilot study

scientific article published on 12 December 2013

Effectiveness of different dosing regimens of risperidone and olanzapine in schizophrenia

scientific article published on 9 January 2015

Effects of Extended Cannabis Abstinence on Cognitive Outcomes in Cannabis Dependent Patients with Schizophrenia vs Non-Psychiatric Controls

scientific article published on 26 April 2017

Effects of Risperidone and Olanzapine Dose Reduction on Cognitive Function in Stable Patients With Schizophrenia: An Open-Label, Randomized, Controlled, Pilot Study ⬇️

scientific article published on July 1, 2013

Effects of antipsychotics on D3 receptors: a clinical PET study in first episode antipsychotic naive patients with schizophrenia using [11C]-(+)-PHNO.

scientific article published in September 2011

Effects of extended cannabis abstinence on clinical symptoms in cannabis dependent schizophrenia patients versus non-psychiatric controls

scientific article published on 8 March 2017

Effects of intracerebroventricular (ICV) olanzapine on insulin sensitivity and secretion in vivo: an animal model

scientific article published on 13 August 2013

Efficacy of antipsychotic drugs for schizophrenia

scientific article

Effort-based decision making as an objective paradigm for the assessment of motivational deficits in schizophrenia

scientific article

Emerging drugs for antipsychotic-induced tardive dyskinesia: investigational drugs in Phase II and Phase III clinical trials

scientific article published on 13 July 2015

Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics

scientific article published in September 2004

Estimated dopamine D2 receptor occupancy from plasma concentrations of atypical antipsychotics and subjective experience/drug attitude in schizophrenia: an analysis of the CATIE data

scientific article

Estimated dopamine D₂ receptor occupancy and remission in schizophrenia: analysis of the CATIE data

scientific article

Estimating endogenous dopamine levels at D2 and D3 receptors in humans using the agonist radiotracer [(11)C]-(+)-PHNO

scientific article

Estimating the effect of endogenous dopamine on baseline [(11) C]-(+)-PHNO binding in the human brain

scientific article published on 24 June 2016

Evaluation of an Educational Program for Clinical Pharmacists to Conduct Standardized Assessments for Medication-Induced Movement-Related Disorders

scientific article published on May 2015

Examination of the validity of the Brief Neurocognitive Assessment (BNA) for schizophrenia

scientific article published on 23 May 2015

Examining levels of antipsychotic adherence to better understand nonadherence

scientific article published in April 2013

Examining strategies to improve accelerometer compliance for individuals living with schizophrenia

scientific article published on 22 September 2014

Examining the efficacy and feasibility of exercise counseling in individuals with schizophrenia: A single-case experimental study

Exploring the neural correlates of delusions of reference

scientific article

Expression of dopamine D2 and D3 receptors in the human retina revealed by positron emission tomography and targeted mass spectrometry

scholarly article by Fernando Caravaggio et al published October 2018 in Experimental Eye Research

Extrapyramidal Side Effects

scientific article

Extrapyramidal symptoms and cognitive test performance in patients with schizophrenia

scientific article published in December 2014

F121. DOES RELAPSE CONTRIBUTE TO TREATMENT RESISTANCE? ANTIPSYCHOTIC RESPONSE IN FIRST- VS. SECOND-EPISODE SCHIZOPHRENIA.

scientific article published in April 2018

F178. NEUROANATOMICAL PROFILES OF TREATMENT-RESISTANCE IN PATIENTS WITH SCHIZOPHRENIA.

scientific article

F219. NOVEL OBJECTIVE ASSESSMENT OF ACTIVITY ENGAGEMENT IN SCHIZOPHRENIA USING WIRELESS MOTION CAPTURE.

scientific article published in April 2018

F224. UTILITY OF SALIVA FOR MONITORING OF CLOZAPINE LEVELS.

scientific article

F225. LEVODOPA AUGMENTATION OF ANTIPSYCHOTICS FOR THE TREATMENT OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA.

scientific article

F235. DIFFERENTIAL EFFECTS OF ANTIPSYCHOTICS ON NEUROINFLAMMATION AND ENERGY SENSING IN A HYPOTHALAMIC CELL LINE.

scientific article

Factors associated with drug attitude in patients with schizophrenia spectrum disorders

scientific article published on 25 January 2017

Further neuroimaging evidence for the deficit subtype of schizophrenia: a cortical connectomics analysis

scientific article published in May 2015

GWAS analysis of treatment resistant schizophrenia: interaction effect of childhood trauma

scientific article published on 28 April 2017

Genetic association analysis of N-methyl-D-aspartate receptor subunit gene GRIN2B and clinical response to clozapine

scientific article published on 15 February 2016

Genetic study of BDNF, DRD3, and their interaction in tardive dyskinesia

scientific article published on 13 February 2009

Genetic study of eight AKT1 gene polymorphisms and their interaction with DRD2 gene polymorphisms in tardive dyskinesia

scientific article published on 5 October 2008

Genetic study of neuregulin 1 and receptor tyrosine-protein kinase erbB-4 in tardive dyskinesia

scientific article

Genetics of Antipsychotic-induced Side Effects and Agranulocytosis ⬇️

scientific article published on April 1, 2011

Genetics of tardive dyskinesia: Promising leads and ways forward

scientific article published on 5 February 2018

Genome-wide association analysis to predict optimal antipsychotic dosage in schizophrenia: a pilot study

scientific article published on 28 January 2016

Glial cell line-derived neurotrophic factor receptor alpha 2 (GFRA2) gene is associated with tardive dyskinesia.

scientific article published on 6 April 2010

Glutamate-mediated excitotoxicity in schizophrenia: a review

scientific article

Glutamatergic Neurometabolite Levels in Patients With Ultra-Treatment-Resistant Schizophrenia: A Cross-Sectional 3T Proton Magnetic Resonance Spectroscopy Study

scientific article published on 26 September 2018

Gradual vs. wait-and-gradual discontinuation in antipsychotic switching: A meta-analysis

scientific article published on 24 February 2017

Guidelines for the Pharmacotherapy of Schizophrenia in Adults

scientific article

Happiness in first-episode schizophrenia ⬇️

scientific article published on August 15, 2012

How much are atypical antipsychotic agents being used, and do they reach the populations who need them? A Canadian experience

scientific article published in September 2002

Hyperinsulinemia in psychiatric patients treated with olanzapine

scientific article published in January 2002

Illness denial in schizophrenia spectrum disorders: a function of left hemisphere dominance

scientific article

Immediate vs Gradual Discontinuation in Antipsychotic Switching: A Systematic Review and Meta-analysis

scientific article published on January 2017

Impact of feedback from pharmacists in reducing antipsychotic polypharmacy in schizophrenia ⬇️

scientific article published on December 1, 2011

Impact of haloperidol, a dopamine D2 antagonist, on cognition and mood

scientific article published on 6 May 2006

Impact of once- versus twice-daily perphenazine dosing on clinical outcomes: an analysis of the CATIE data

scientific article

Impaired insight into illness and cognitive insight in schizophrenia spectrum disorders: resting state functional connectivity

scientific article published on 8 November 2014

Impairments in both reward and punishment guided reinforcement learning in schizophrenia

scientific article published on 6 September 2013

Improving symptoms and side effects in older patients with schizophrenia with decreasing dopamine D2/3 receptor occupancy following risperidone and olanzapine dose reduction

scientific article published on 12 October 2015

Incentive motivation deficits in schizophrenia reflect effort computation impairments during cost-benefit decision-making

scientific article published on 28 August 2013

Incidence of Antipsychotic-Associated Side Effects: Impact of Clinician Versus Patient Ratings and Change Versus Absolute Scores

scientific article

Increased stress-induced dopamine release in psychosis

scientific article published on 30 November 2011

Insight and subjective measures of quality of life in chronic schizophrenia

scientific article published on 9 June 2015

Insulin resistance and adiponectin levels in drug-free patients with schizophrenia: A preliminary report

scientific article published in May 2006

Insulin resistance and decreased glucose-stimulated insulin secretion after acute olanzapine administration

scientific article

Insulin resistance and secretion in vivo: effects of different antipsychotics in an animal model

scientific article published on 20 January 2009

Insulin resistance following continuous, chronic olanzapine treatment: an animal model

scientific article published in September 2008

Interpreting a Multivariate Analysis of Functional Neuroimaging Data ⬇️

scientific article published on May 29, 2012

Interventions to reduce weight gain in schizophrenia

scientific article published on 21 April 2007

Intranasal oxytocin does not modulate jumping to conclusions in schizophrenia: Potential interactions with caudate volume and baseline social functioning

scientific article

Invalid responding in questionnaire-based research: Implications for the study of schizotypy ⬇️

scientific article published on July 1, 2013

Investigating consummatory and anticipatory pleasure across motivation deficits in schizophrenia and healthy controls

scientific article published on 23 April 2017

Investigating the predictors of happiness, life satisfaction and success in schizophrenia

scientific article published on 22 November 2017

Investigation of the Gene in Tardive Dyskinesia - New Data and Meta-Analysis

article

Investigational drugs for schizophrenia targeting the dopamine receptor: Phase II trials ⬇️

scientific article published on May 3, 2013

Is psychiatry ignoring suicide? The case for clozapine

scientific article published in June 2012

Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis

scientific article published on 10 February 2017

Lack of association between dopaminergic antagonism and negative symptoms in schizophrenia: a positron emission tomography dopamine D2/3 receptor occupancy study

scientific article published on 24 August 2016

Lack of association of NALCN genetic variants with schizophrenia

scientific article published on 31 July 2010

Lack of effect of risperidone or olanzapine dose reduction on metabolic parameters, prolactin, and corrected QT interval in stable patients with schizophrenia

scientific article published in August 2014

Lack of effect of risperidone or olanzapine dose reduction on subjective experiences in stable patients with schizophrenia

scientific article published on 16 April 2014

Life satisfaction among individuals with schizophrenia in the Clinical Antipsychotic Trial of Intervention Effectiveness (CATIE) study

scientific article

Life satisfaction and happiness among young adults with schizophrenia

scientific article published in June 2016

Lipoic acid and haloperidol-induced vacuous chewing movements: Implications for prophylactic antioxidant use in tardive dyskinesia

scientific article published on 24 August 2016

Liver enzyme CYP2D6 gene and tardive dyskinesia

scientific article published on 24 September 2020

Long-acting injectable antipsychotics in the treatment of schizophrenia: their role in relapse prevention

scientific article published on October 2010

M103. Treating Motivation Deficits in Schizophrenia With a Virtual Reality Motivation Training Program.

scientific article

M2. Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis.

scientific article

M31. An Investigation of Feedback-Guided Decision-Making in Schizophrenia.

scientific article published on 20 March 2017

M58. Sedentary Behavior Profiles and Obesity Among People With Schizophrenia.

scientific article published on 20 March 2017

MDR1 gene in tardive dyskinesia scale scores: comparison of strategies for quantitative trait haplotype analysis

scientific article published on 17 March 2009

Management of schizophrenia in late life with antipsychotic medications: a qualitative review

scientific article published on December 2011

Mean platelet volume in schizophrenia unaltered after 1year of clozapine exposure

scientific article published on 3 June 2014

Measuring motivation in people with schizophrenia

scientific article

Measuring the effects of treatment with antipsychotics

scientific article published in May 2015

Meta-regression analysis of placebo response in antipsychotic trials, 1970-2010.

scientific article

Methamphetamine Use and Schizophrenia: A Population-Based Cohort Study in California ⬇️

scientific article published on April 1, 2012

Monthly administration of long-acting injectable risperidone and striatal dopamine D2 receptor occupancy for the management of schizophrenia.

scientific article published on August 2008

Motivation and Social Cognition in Patients with Schizophrenia

scientific article

Motivational deficits and cognitive test performance in schizophrenia

scientific article published on September 2014

Motivational deficits in early schizophrenia: prevalent, persistent, and key determinants of functional outcome

scientific article published on 15 May 2015

Motivational deficits in major depressive disorder: Cross-sectional and longitudinal relationships with functional impairment and subjective well-being

scientific article

Negative symptoms in schizophrenia: avolition and Occam's razor

scientific article

Negative symptoms of schizophrenia: clinical features, relevance to real world functioning and specificity versus other CNS disorders

scientific article

Neural substrates underlying effort computation in schizophrenia

scientific article published on 12 September 2013

Neurocognitive Benefits of Second-Generation Antipsychotics Versus Placebo: Insufficient Evidence Based on a Systematic Review

scientific article published on 26 January 2017

Neurocognitive impairment in the deficit subtype of schizophrenia

scientific article published on 11 August 2015

Neuroimaging evidence for the deficit subtype of schizophrenia

scientific article published in May 2013

Neuroimaging findings in schizotypal personality disorder: A systematic review ⬇️

scientific article published on 05 December 2012

Neuroimaging findings in treatment-resistant schizophrenia: A systematic review: Lack of neuroimaging correlates of treatment-resistant schizophrenia

scientific article

Neuroimaging predictors of functional outcomes in schizophrenia at baseline and 6-month follow-up

scientific article

Neurometabolite levels in antipsychotic-naïve/free patients with schizophrenia: A systematic review and meta-analysis of 1H-MRS studies

scientific article published on 23 March 2018

New insights into tardive dyskinesia genetics: Implementation of whole-exome sequencing approach

scientific article published on 30 May 2019

O10.6. OLANZAPINE IMPAIRS CENTRAL INSULIN ACTION: EFFECTS ON BODY FUEL PREFERENCE IN RATS.

scientific article

Objective assessment of exploratory behaviour in schizophrenia using wireless motion capture

scientific article published on 24 September 2017

Off-label antipsychotic use and tardive dyskinesia in at-risk populations: new drugs with old side effects

scientific article published on January 2014

One-year symptom trajectories in patients with stable schizophrenia maintained on antipsychotics versus placebo: meta-analysis

scientific article published on 18 May 2017

Oxidative stress and the antipsychotic-induced vacuous chewing movement model of tardive dyskinesia: evidence for antioxidant-based prevention strategies

scientific article published on 22 April 2014

Oxidative stress in tardive dyskinesia: genetic association study and meta-analysis of NADPH quinine oxidoreductase 1 (NQO1) and Superoxide dismutase 2 (SOD2, MnSOD) genes

scientific article published on 22 September 2009

Patterns of tobacco-related mortality among individuals diagnosed with schizophrenia, bipolar disorder, or depression.

scientific article published on 27 September 2013

Personal Recovery in Serious Mental Illness: Making Sense of the Concept

scientific article

Pharmacogenetic Analysis of Functional Glutamate System Gene Variants and Clinical Response to Clozapine

scientific article

Pharmacological interventions for reducing weight gain in schizophrenia

scientific article

Phosphodiesterase 4B genetic variants are not associated with antipsychotic-induced tardive dyskinesia

scientific article published in September 2010

Physical activity preferences of individuals diagnosed with schizophrenia or bipolar disorder

scientific article

Placebo response trajectories in short-term and long-term antipsychotic trials in schizophrenia

scientific article published on 27 August 2011

Positive symptoms are associated with clinicians' global impression in treatment-resistant schizophrenia

scientific article

Practice and Learning: Spatiotemporal Differences in Thalamo-Cortical-Cerebellar Networks Engagement across Learning Phases in Schizophrenia

scientific article published on January 2016

Prediction of brain clozapine and norclozapine concentrations in humans from a scaled pharmacokinetic model for rat brain and plasma pharmacokinetics

scientific article

Prediction of working memory performance in schizophrenia by plasma ratio of clozapine to N-desmethylclozapine

scientific article published on 10 April 2015

Predictors and markers of clozapine response

scientific article

Progress in defining optimal treatment outcome in schizophrenia

scientific article published on January 2010

Prolactin as a biomarker for treatment response and tardive dyskinesia in schizophrenia subjects: old thoughts revisited from a genetic perspective

scientific article published in January 2011

Psychometric evaluation of the Readiness for Discharge Questionnaire

scientific article published on 15 August 2005

Quantifying intraindividual variations in plasma clozapine levels: a population pharmacokinetic approach

scientific article published on 12 April 2016

Rapid vs. slow antipsychotic initiation in schizophrenia: A systematic review and meta-analysis

scientific article published on 22 August 2017

Rat brain CYP2D enzymatic metabolism alters acute and chronic haloperidol side-effects by different mechanisms

scientific article published on 25 April 2017

Rational pharmacotherapy in early psychosis

scientific article published in August 2005

Recent advances in understanding and mitigating adipogenic and metabolic effects of antipsychotic drugs

scientific article

Reduced insulin sensitivity is related to less endogenous dopamine at D2/3 receptors in the ventral striatum of healthy nonobese humans

scientific article

Reduced insulin sensitivity may be related to less striatal glutamate: An 1H-MRS study in healthy non-obese humans

scientific article published on 18 December 2017

Reduced insulin-receptor mediated modulation of striatal dopamine release by basal insulin as a possible contributing factor to hyperdopaminergia in schizophrenia

scientific article

Refractory schizophrenia: adding aripiprazole to clozapine reduces negative but not overall symptoms.

scientific article published in May 2009

Relationship between clinical improvement and functional gains with clozapine in schizophrenia

scientific article published on 12 August 2014

Relationship between symptomatic improvement and overall illness severity in patients with schizophrenia

scientific article

Reliability of a patient-reported outcome measure in schizophrenia: Results from back-to-back self-ratings

scientific article published on 27 July 2016

Remission: what's in a name?

scientific article

Review: amisulpride is effective and safe for schizophrenia

scientific article

Review: insufficient evidence to guide use of drugs for clozapine induced hypersalivation

scientific article published on February 2009

Review: maintenance antipsychotics prevent relapse in patients with schizophrenia ⬇️

scientific article published on August 17, 2012

Revisiting the International Physical Activity Questionnaire (IPAQ): Assessing physical activity among individuals with schizophrenia

scientific article published on 9 September 2016

Reward motivation in humans and its relationship to dopamine D2/3 receptor availability: A pilot study with dual [11C]-raclopride and [11C]-(+)-PHNO imaging

scientific article published in February 2018

Risk of neutropenia in a clozapine-treated elderly population

scientific article

Role of ethnicity in antipsychotic-induced weight gain and tardive dyskinesia: genes or environment?

scientific article

S16. GLUTAMATERGIC NEUROMETABOLITE LEVELS IN PATIENTS WITH TREATMENT-RESISTANT SCHIZOPHRENIA: A CROSS-SECTIONAL 3T PROTON MRS STUDY.

scientific article

S175. AMOTIVATION IS ASSOCIATED WITH SMALLER VENTRAL STRIATUM VOLUMES IN OLDER PATIENTS WITH SCHIZOPHRENIA.

scientific article published in April 2018

S225. A SYSTEMATIC REVIEW AND META-ANALYSIS OF PHARMACOLOGICAL INTERVENTIONS FOR REDUCTION OR PREVENTION OF WEIGHT GAIN IN SCHIZOPHRENIA.

scientific article

S229. CAN LONG-ACTING INJECTABLE PALIPERIDONE DOSING BE OPTIMIZED WITH PLASMA LEVEL MEASUREMENTS?

scientific article

S76. A BEHAVIOURAL ECONOMIC ANALYSIS OF EFFORT-RELATED CHOICE IN SCHIZOPHRENIA.

scientific article

SA109. Examining Reward Responsiveness and Expectancy Across a Dimension of Motivation Deficits in Schizophrenia.

scientific article

SA118. Intranasal Oxytocin Does Not Modulate Jumping to Conclusion: S in Schizophrenia: Potential Interaction With Baseline Social Functioning.

scientific article published on 20 March 2017

SU118. Cognitive Impairment and Clozapine Response in Treatment-Resistant Schizophrenia—A Cross-Sectional Study

scientific article

SU84. Neurometabolite Levels in Antipsychotic Naive/Free Patients With Schizophrenia: A Meta-Analysis of 1H-MRS Studies.

scientific article

Schizophrenia as a disorder of too little dopamine: implications for symptoms and treatment ⬇️

scientific article published on April 1, 2011

Schizophrenia as a lifelong illness: implications for care

scientific article

Schizophrenia, antipsychotics, and the metabolic syndrome: is there a silver lining?

scientific article published on 01 July 2006

Schizophrenia, cognition, and psychosis

scientific article published in March 2014

Schizophrenia-associated gene dysbindin-1 and tardive dyskinesia

scientific article published on 11 May 2020

Schizophrenia: no health without physical health

scientific article published in May 2014

Simulating real world functioning in schizophrenia using a naturalistic city environment and single-trial, goal-directed navigation

scientific article

Striatal neurometabolite levels in patients with schizophrenia undergoing long-term antipsychotic treatment: A proton magnetic resonance spectroscopy and reliability study

scientific article published on 31 January 2018

Subtyping Schizophrenia by Treatment Response: Antipsychotic Development and the Central Role of Positive Symptoms

scientific article

Suicide in schizophrenia: an observational study of coroner records in Toronto

scientific article published on January 2015

Switching atypical antipsychotics: a review

scientific article published on December 2004

Switching from 2 antipsychotics to 1 antipsychotic in schizophrenia: a randomized, double-blind, placebo-controlled study

scientific article published on January 2016

Switching to Clozapine Using Immediate Versus Gradual Antipsychotic Discontinuation: A Pilot, Double-Blind, Randomized Controlled Trial

scientific article published on February 2017

T7. PHARMACOGENETIC OF TARDIVE DYSKINESIA -- A FOLLOW-UP ON THE VALBENAZINE TARGET VMAT2/SLC18A2.

scientific article published in April 2018

Tardive dyskinesia in relation to estimated dopamine D2 receptor occupancy in patients with schizophrenia: analysis of the CATIE data

scientific article

Tardive dyskinesia: eliminated, forgotten, or overshadowed?

scientific article

Targeting the dopamine receptor in schizophrenia: investigational drugs in Phase III trials

scientific article

Tetrabenazine augmentation in treatment-resistant schizophrenia: a 12-week, double-blind, placebo-controlled trial

scientific article

The Effect of Clozapine on Hematological Indices: A 1-Year Follow-Up Study

scientific article

The Effects of Valbenazine in Participants with Tardive Dyskinesia: Results of the 1-Year KINECT 3 Extension Study.

scientific article published on 14 November 2017

The Pharmacology of Typical and Atypical Antipsychotics

scholarly article

The VAGUS insight into psychosis scale--self-report and clinician-rated versions

scientific article published on 19 August 2014

The catechol-O-methyl-transferase gene in tardive dyskinesia

scientific article published in September 2010

The crossover approach to switching antipsychotics: what is the evidence?

scientific article

The effect of an acute bout of exercise on executive function among individuals with schizophrenia

scientific article published in November 2016

The effects of buspirone on occupancy of dopamine receptors and the rat gambling task

scientific article published on 19 August 2017

The neural correlates of apathy in schizophrenia: An exploratory investigation

scientific article published on 24 October 2017

The neurobiology of relapse in schizophrenia

scientific article published on 24 October 2013

The newer antipsychotics: underlying mechanisms and the new clinical realities

The relationship between dopamine D2 receptor occupancy and the vacuous chewing movement syndrome in rats

scientific article published in November 2002

The relationship between subcortical brain volume and striatal dopamine D2/3 receptor availability in healthy humans assessed with [(11) C]-raclopride and [(11) C]-(+)-PHNO PET.

scientific article

The use of electronic monitoring (MEMS) to evaluate antipsychotic compliance in outpatients with schizophrenia

scientific article published on 08 January 2007

The use of pharmacotherapy in the prodrome of schizophrenia

scientific article published in August 2004

The vacuous chewing movement (VCM) model of tardive dyskinesia revisited: is there a relationship to dopamine D(2) receptor occupancy?

scientific article

Therapeutic drug monitoring of clozapine: sampling error as a source of variance

scientific article published in December 2014

Time course of improvement with antipsychotic medication in treatment-resistant schizophrenia

scientific article published on October 2011

Topiramate augmentation in clozapine-treated patients with schizophrenia: clinical and metabolic effects

scientific article published on December 2010

Topiramate in schizophrenia: a review of effects on psychopathology and metabolic parameters

scientific article

Toward a more parsimonious assessment of neurocognition in schizophrenia: a 10-minute assessment tool

scientific article published on 24 January 2014

Trait Anhedonia in Schizophrenia: A Systematic Review and Comparative Meta-analysis

scientific article published in 2021

Trait impulsiveness is related to smaller post-commissural putamen volumes in males but not females

scientific article published on 22 August 2017

Transient tardive dystonia: overview and case presentation

scientific article published in July 2008

Treating Negative Symptoms in Schizophrenia: an Update

scientific article

Treatment of clozapine-induced hypersalivation with ipratropium bromide: a randomized, double-blind, placebo-controlled crossover study

scientific article published on August 2009

Treatment of schizophrenia with long-acting injectable risperidone: a 12-month open-label trial of the first long-acting second-generation antipsychotic

scientific article

Treatment resistant schizophrenia and response to antipsychotics: a review

scientific article published on 14 October 2011

Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology

scientific article published on 6 December 2016

Understanding antipsychotic "atypicality": a clinical and pharmacological moving target

scientific article

Use of Atypical Antipsychotics During Pregnancy and the Risk of Neural Tube Defects in Infants ⬇️

scientific article published on January 1, 2002

Use of candidate gene markers to guide antipsychotic dosage adjustment

scientific article

Using poverty of speech as a case study to explore the overlap between negative symptoms and cognitive dysfunction

scientific article published on 27 May 2016

Using treatment response to subtype schizophrenia: proposal for a new paradigm in classification

scientific article published on 17 September 2013

Valbenazine for Tardive Dyskinesia

scientific article published on January 2017

Validation of a physical activity assessment tool for individuals with schizophrenia

scientific article published on 19 December 2005

Validation of an abbreviated quality of life scale for schizophrenia

scientific article published on 9 December 2012

Values in First-Episode Schizophrenia

scientific article

What symptom domains are associated with patient distress in schizophrenia?

scientific article published on 31 May 2016

Where to Position Clozapine: Re-Examining the Evidence ⬇️

scientific article published on October 1, 2010

Paulina is supported by:

About Paulina

Help